Using SH-SY5Y neuroblast-like cells as a model for drug-induced PD, it was shown that miR-181a-3p was transferred via EVs from MSCs to the SH-SY5Y cells, where it affected the p38 MAPK pathway by inhibiting EGR1. Here, EGR1 is linked to Parkinson disease.